Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada.

Argento E, Capler R, Thomas G, Lucas P, Tupper KW.

Drug Alcohol Rev. 2019 Sep 5. doi: 10.1111/dar.12985. [Epub ahead of print]

PMID:
31489731
2.

"We don't got that kind of time, man. We're trying to get high!": Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs.

Bardwell G, Boyd J, Tupper KW, Kerr T.

Int J Drug Policy. 2019 Jul 20;71:125-132. doi: 10.1016/j.drugpo.2019.06.018. [Epub ahead of print]

PMID:
31336258
3.

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.

Argento E, Tupper KW, Socias ME.

Int J Drug Policy. 2019 Apr;66:80-81. doi: 10.1016/j.drugpo.2018.11.006. Epub 2019 Feb 7.

PMID:
30743091
4.

An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders.

Renelli M, Fletcher J, Tupper KW, Files N, Loizaga-Velder A, Lafrance A.

Eat Weight Disord. 2018 Nov 24. doi: 10.1007/s40519-018-0619-6. [Epub ahead of print]

PMID:
30474794
5.

3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth.

Lake S, Gaddis A, Tupper KW, Nosova E, DeBeck K.

Subst Abus. 2018 Nov 20:1-6. doi: 10.1080/08897077.2018.1528493. [Epub ahead of print]

PMID:
30457939
6.

Drug checking as a potential strategic overdose response in the fentanyl era.

Laing MK, Tupper KW, Fairbairn N.

Int J Drug Policy. 2018 Dec;62:59-66. doi: 10.1016/j.drugpo.2018.10.001. Epub 2018 Oct 22.

PMID:
30359874
7.

Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia.

Mema SC, Sage C, Xu Y, Tupper KW, Ziemianowicz D, McCrae K, Leigh M, Munn MB, Taylor D, Corneil T.

Can J Public Health. 2018 Dec;109(5-6):740-744. doi: 10.17269/s41997-018-0126-6. Epub 2018 Sep 24.

PMID:
30251119
8.

Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.

Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E.

Drug Alcohol Depend. 2018 Sep 1;190:242-245. doi: 10.1016/j.drugalcdep.2018.06.020. Epub 2018 Jul 24.

PMID:
30064061
9.

Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders.

Lafrance A, Loizaga-Velder A, Fletcher J, Renelli M, Files N, Tupper KW.

J Psychoactive Drugs. 2017 Nov-Dec;49(5):427-435. doi: 10.1080/02791072.2017.1361559. Epub 2017 Sep 12.

PMID:
28895501
10.

A Public-Health-Based Vision for the Management and Regulation of Psychedelics.

Haden M, Emerson B, Tupper KW.

J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.

PMID:
27430375
11.

Psychedelic medicine: a re-emerging therapeutic paradigm.

Tupper KW, Wood E, Yensen R, Johnson MW.

CMAJ. 2015 Oct 6;187(14):1054-1059. doi: 10.1503/cmaj.141124. Epub 2015 Sep 8. Review. No abstract available.

12.
13.

Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada.

Thomas G, Lucas P, Capler NR, Tupper KW, Martin G.

Curr Drug Abuse Rev. 2013 Mar;6(1):30-42.

PMID:
23627784
14.

Statement on ayahuasca.

Anderson BT, Labate BC, Meyer M, Tupper KW, Barbosa PC, Grob CS, Dawson A, McKenna D.

Int J Drug Policy. 2012 May;23(3):173-5. doi: 10.1016/j.drugpo.2012.02.007. Epub 2012 Mar 27. No abstract available.

PMID:
22459485
15.

The globalization of ayahuasca: harm reduction or benefit maximization?

Tupper KW.

Int J Drug Policy. 2008 Aug;19(4):297-303. doi: 10.1016/j.drugpo.2006.11.001. Epub 2006 Dec 4.

PMID:
18638702
16.

A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.

Callaway JC, Grob CS, McKenna DJ, Nichols DE, Shulgin A, Tupper KW.

J Anal Toxicol. 2006 Jul-Aug;30(6):406-7; author reply 407. No abstract available.

PMID:
16872575

Supplemental Content

Loading ...
Support Center